• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

CNS Summit 2017 Abstracts of Poster Presentations
Conclusion: This novel technology discriminates and quantifies subtle differences in behavior and neurological impairments in subjects afflicted with neurological injury/disease. KINARM assessments can be incorporated into multi-center trials (e.g., monitoring stroke motor recovery: NCT02928393). Further studies will determine if KINARM Labs can demonstrate a clinical effect with fewer subjects over a shorter trial period. Disclosures/funding: Dr. Stephen Scott is the inventor of KINARM and CSO of BKIN Technologies.   Multiplexed mass spectrometry assay identifies neurodegeneration biomarkers in CSF Presenter: Chelsky...
Source: Innovations in Clinical Neuroscience - November 1, 2017 Category: Neuroscience Authors: ICNS Online Editor Tags: Assessment Tools biomarkers Cognition Current Issue Drug Development General Genetics Medical Issues Neurology Patient Assessment Psychopharmacology Scales Special Issues Supplements Trial Methodology clinical trials CNS Su Source Type: research

Chris Cornell: When Suicide Doesn't Make Sense
By Julie A. Fast Sometimes, people commit suicide and it does make some sense. It’s scary and upsets our world, but on a basic level we think we understand. The suicide of Robin Williams comes to mind. He had a history of depression and his health was failing. Oh how we all wish he could have found more help, but I don’t think it was as much surprising as it was devastating and sad for the millions who loved him when he died. Then there are suicides that make no sense. They don’t fit in the current life of the person or fit what the person is actually saying about life in public. The partner or other love...
Source: Healthy Living - The Huffington Post - May 18, 2017 Category: Consumer Health News Source Type: news